Weight-Based Chemotherapy Dosing in Obese Patients With Cancer: Back to the Future

被引：20

作者：

Lyman, Gary H. ^{[1
,2
]}

机构：

[1] Duke Univ, Comparat Effect & Outcomes Res Oncol, Durham, NC 27706 USA

[2] Duke Canc Inst, Durham, NC USA

来源：

JOURNAL OF ONCOLOGY PRACTICE | 2012年 / 8卷 / 04期

关键词：

D O I：

10.1200/JOP.2012.000606

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E62 / E64

页数：3

共 34 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[3] OBESITY AS AN ADVERSE PROGNOSTIC FACTOR FOR PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER [J].

BASTARRACHEA, J ;

HORTOBAGYI, GN ;

SMITH, TL ;

KAU, SWC ;

BUZDAR, AU .

ANNALS OF INTERNAL MEDICINE, 1994, 120 (01) :18-25

[4] CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].

BONADONNA, G ;

VALAGUSSA, P ;

MOLITERNI, A ;

ZAMBETTI, M ;

BRAMBILLA, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906

[5] Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer:: 10-year follow-up results of The French Adjuvant Study Group 05 randomized trial [J].

Bonneterre, J ;

Roché, H ;

Kerbrat, P ;

Brémond, A ;

Fumoleau, P ;

Namer, M ;

Goudier, MJ ;

Schraub, S ;

Fargeot, P ;

Chapelle-Marcillac, I .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2686-2693

[6] Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer [J].

Budman, DR ;

Berry, DA ;

Cirrincione, CT ;

Henderson, IC ;

Wood, WC ;

Weiss, RB ;

Ferree, CR ;

Muss, HB ;

Green, MR ;

Norton, L ;

Frei, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (16) :1205-1211

[7] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[8]

Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0

[9] Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials [J].

Di Maio, M ;

Gridelli, C ;

Gallo, C ;

Shepherd, F ;

Piantedosi, FV ;

Cigolari, S ;

Manzione, L ;

Illiano, A ;

Barbera, S ;

Robbiati, SF ;

Frontini, L ;

Piazza, E ;

Ianniello, GP ;

Veltri, E ;

Castiglione, F ;

Rosetti, F ;

Gebbia, V ;

Seymour, L ;

Chiodini, P ;

Perrone, F .

LANCET ONCOLOGY, 2005, 6 (09) :669-677

[10] Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide Survey [J].

Field, Kathryn M. ;

Kosmider, Suzanne ;

Jefford, Michael ;

Michael, Michael ;

Jennens, Ross ;

Green, Michael ;

Gibbs, Peter .

JOURNAL OF ONCOLOGY PRACTICE, 2008, 4 (03) :108-113

← 1 2 3 4 →